GlassScriptPhysician profile
Weijia Li
NPI 1588227888
$10,672.08
in general payments reported to CMS, 2019-2025
6 companies · $6,550 in 2025
The $6,550 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,290 · 2024: $1,832 · 2025: $6,550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,460 · Food and Beverage: $3,463 · Grant: $2,500 · Education: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,459.82 |
| Food and Beverage | $3,462.66 |
| Grant | $2,500.00 |
| Education | $249.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,136.53 | 2023-2025 | Advisa Dr Mri Surescan, Harmony, Micra |
| Boston Scientific Corporation | $3,493.23 | 2025 | General - Therapies |
| Biotronik INC. | $2,624.57 | 2023-2025 | Amvia Edge, Pamira, Solia |
| Biosense Webster, INC. | $325.34 | 2024-2025 | Carto 3, Soundstar, Nuvision Ice Catheter |
| Atricure, INC. | $50.71 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax, Epi-Ease Epicardial Access System, Atriclip Laa Exclusion System |
| Abiomed | $41.70 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Weijia Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.